
|Videos|November 7, 2021
Expert Discusses Cardiovascular Effects of CKD
Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses the cardiovascular effects of chronic kidney disease.
Advertisement
In a Pharmacy Times® interview, Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, about his ASN 2021 Kidney Week presentation on the prevention of vascular calcification in chronic kidney disease (CKD).
He discussed the cardiovascular effects of CKD.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
3
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
4
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
5














































































































































































































